Diabetes Type 1 Market and Forecast Analysis to 2025

NEW YORK, June 4, 2019 /PRNewswire/ --

DISEASE OVERVIEW
Diabetes mellitus is a group of chronic endocrine disorders characterized by hyperglycemia due to insufficient levels of insulin, a hormone responsible for regulating blood sugar. Type 1 diabetes accounts for around 5–10% of the total diabetic population. The majority of cases of type 1 diabetes may be classified as type 1a, an autoimmune disease characterized by the destruction of pancreatic beta cells, with a minority of cases making up type 1b, which is described as idiopathic diabetes mellitus.



Read the full report: https://www.reportlinker.com/p05780227/?utm_source=PRN


MARKET SNAPSHOT

Biosimilars stifle the impact of oral therapies and longer-acting basal insulins, causing only moderate market growth.
Datamonitor Healthcare's diabetes survey indicates biosimilar erosion will majorly impact the basal insulin market.
Type 1 diabetes cases continue to increase but limitations in the understanding of etiology limit prevention efforts.
Biosimilar insulin glargine and novel insulin products are threatening Lantus's longstanding dominance of the long-acting basal insulin market.
Concerns over diabetic ketoacidosis will be the biggest roadblock to SGLT-2 inhibitors' approval and uptake.

Read the full report: https://www.reportlinker.com/p05780227/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/diabetes-type-1-market-and-forecast-analysis-to-2025-300861928.html

SOURCE Reportlinker